Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Michael T Tetzlaff

Showing results (21-30 of 224) with videos related to

Pageof 23
Sort By:
International Journal of Gynecological Pathology : Official Journal of the International Society of Gynecological Pathologists|December 20, 2019
Variable Expression of MSH6 in Endometrial Carcinomas With Intact Mismatch Repair and With MLH1 Loss Due to MLH1 MethylationNidhi Tandon, Courtney Hudgens, Bryan Fellman, et al.
Head & Neck|November 1, 2007
Report of a case of sinonasal undifferentiated carcinoma arising in a background of extensive nasal gliomatosisMichael T Tetzlaff, Peter Liu, Bert W O'Malley, et al.
Journal of Cutaneous Pathology|May 7, 2016
Histopathologic and mutational analysis of a case of blue nevus-like melanomaJulia Dai, Michael T Tetzlaff, Lynn M Schuchter, et al.
Journal of Gastrointestinal Oncology|June 2, 2015
Capecitabine-induced leukocytoclastic vasculitis under neoadjuvant chemotherapy for locally advanced colorectal cancerHumaid O Al-Shamsi, Bryan K Kee, Michael T Tetzlaff, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|October 7, 2018
Identification of a subset of microsatellite-stable endometrial carcinoma with high PD-L1 and CD8+ lymphocytesSuzanne Crumley, Katherine Kurnit, Courtney Hudgens, et al.
JAMA Dermatology|October 6, 2017
Brentuximab Vedotin for Patients With Refractory Lymphomatoid Papulosis: An Analysis of Phase 2 ResultsDaniel J Lewis, Rakhshandra Talpur, Auris O Huen, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|August 12, 2015
Results of a Phase II Trial of Brentuximab Vedotin for CD30+ Cutaneous T-Cell Lymphoma and Lymphomatoid PapulosisMadeleine Duvic, Michael T Tetzlaff, Pamela Gangar, et al.
Clinics in Laboratory Medicine|August 14, 2017
Toward a Molecular-Genetic Classification of Spitzoid NeoplasmsMichael T Tetzlaff, Alexandre Reuben, Steven D Billings, et al.
Cutis|May 13, 2014
Primary cutaneous Candida tropicalis infection in a patient with B-cell lymphomaAlison M Schram, Brian Kim, Casey Carlos, et al.
Laboratory Investigation; a Journal of Technical Methods and Pathology|April 25, 2012
Loss of microRNA-205 expression is associated with melanoma progressionShujing Liu, Michael T Tetzlaff, Aihua Liu, et al.
Pageof 23

Showing results (21-30 of 224) with videos related to

Sort By:
Pageof 23
International Journal of Gynecological Pathology : Official Journal of the International Society of Gynecological Pathologists|December 20, 2019
Variable Expression of MSH6 in Endometrial Carcinomas With Intact Mismatch Repair and With MLH1 Loss Due to MLH1 MethylationNidhi Tandon, Courtney Hudgens, Bryan Fellman, et al.
Head & Neck|November 1, 2007
Report of a case of sinonasal undifferentiated carcinoma arising in a background of extensive nasal gliomatosisMichael T Tetzlaff, Peter Liu, Bert W O'Malley, et al.
Journal of Cutaneous Pathology|May 7, 2016
Histopathologic and mutational analysis of a case of blue nevus-like melanomaJulia Dai, Michael T Tetzlaff, Lynn M Schuchter, et al.
Journal of Gastrointestinal Oncology|June 2, 2015
Capecitabine-induced leukocytoclastic vasculitis under neoadjuvant chemotherapy for locally advanced colorectal cancerHumaid O Al-Shamsi, Bryan K Kee, Michael T Tetzlaff, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|October 7, 2018
Identification of a subset of microsatellite-stable endometrial carcinoma with high PD-L1 and CD8+ lymphocytesSuzanne Crumley, Katherine Kurnit, Courtney Hudgens, et al.
JAMA Dermatology|October 6, 2017
Brentuximab Vedotin for Patients With Refractory Lymphomatoid Papulosis: An Analysis of Phase 2 ResultsDaniel J Lewis, Rakhshandra Talpur, Auris O Huen, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|August 12, 2015
Results of a Phase II Trial of Brentuximab Vedotin for CD30+ Cutaneous T-Cell Lymphoma and Lymphomatoid PapulosisMadeleine Duvic, Michael T Tetzlaff, Pamela Gangar, et al.
Clinics in Laboratory Medicine|August 14, 2017
Toward a Molecular-Genetic Classification of Spitzoid NeoplasmsMichael T Tetzlaff, Alexandre Reuben, Steven D Billings, et al.
Cutis|May 13, 2014
Primary cutaneous Candida tropicalis infection in a patient with B-cell lymphomaAlison M Schram, Brian Kim, Casey Carlos, et al.
Laboratory Investigation; a Journal of Technical Methods and Pathology|April 25, 2012
Loss of microRNA-205 expression is associated with melanoma progressionShujing Liu, Michael T Tetzlaff, Aihua Liu, et al.
Pageof 23